<DOC>
	<DOCNO>NCT02649075</DOCNO>
	<brief_summary>The objective study evaluate nutritional therapy SBI ( medical food ) compare placebo clinical dietary management mild moderate Crohn 's disease .</brief_summary>
	<brief_title>To Evaluate SBI Dietary Management Mild Moderate Crohn 's Disease</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , multi-center , pilot study evaluate SBI 10 g BID compare match placebo 12 week follow 12 week open-label extension SBI 10 g BID ( EnteraGam ) dietary management mild moderate Crohn 's disease . The effect SBI evaluate Crohn 's disease relate symptom inflammation symptom control measure Crohn 's disease activity index ( CDAI ) score plasma stool marker inflammation . The patient 's quality life also assess indicator disease state .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Confirmed diagnosis mild moderate Crohn 's disease least 3 month . Screening CDAI &gt; 150 ≤ 250 base subject recall . Average great two liquid soft stool per day abdominal pain intensity score &gt; 1 . Subject least one positive biomarker inflammation : fecal calprotectin &gt; 100 µg/g ; elevate Creactive protein ( CRP ) &gt; 2 mg/dL . Positive stool test pathogenic bacteria include Clostridium difficile O &amp; P . Confirmed intestinal stricture obstructivelike clinical symptom . Bowel resection within previous 6 month . Change medical therapy : must stable dose corticosteroid ( prednisone prednisolone ) less equal 20 mg per day 2 week prior screen , budesonide less equal 9 mg per day 2 week prior screen , 5aminosalicylates 2 week prior screen , immunomodulators 6 week prior screen . Taking great 20 mg per day corticosteroid ( prednisone prednisolone ) great 9 mg budesonide . Received biologic therapy past 2 year . Diagnosis one comorbid condition ( ) require medical surgical therapy may affect bowel function , gastrointestinal symptom . Serious infection 3 month prior enrollment . Allergy intolerance beef ingredient use product . Participated investigational drug device study within 30 day . Does access internet . Taken EnteraGam®</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>IBD</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Crohn 's</keyword>
	<keyword>Crohns</keyword>
	<keyword>SBI</keyword>
	<keyword>Serum-derived bovine immunoglobulin / protein isolate</keyword>
	<keyword>EnteraGam</keyword>
</DOC>